Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share.
-
Shares outstanding
-
9,041,375
-
Total 13F shares
-
1,445,762
-
Share change
-
-758,884
-
Total reported value
-
$4,571,204
-
Price per share
-
$3.16
-
Number of holders
-
17
-
Value change
-
-$2,836,549
-
Number of buys
-
3
-
Number of sells
-
7
Institutional Holders of Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. (BNR) as of Q2 2025
As of 30 Jun 2025,
Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. (BNR) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,445,762 shares.
The largest 10 holders included
Kynam Capital Management, LP, CRCM LP, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Group, Inc., RENAISSANCE TECHNOLOGIES LLC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, BANK OF AMERICA CORP /DE/, CITADEL ADVISORS LLC, HSG Holding Ltd, and MORGAN STANLEY.
This page lists
17
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.